semaglutide for arthritis linked to reduced knee pain in people with obesity, study finds GLP-1 in Joints Suggests Arthritis

Clinical monitoring further enhances outcomes by identifying adjustments needed to maintain alignment with treatment goals

Tirzepatide may be considered when insulin resistance is a major factor because it targets both GIP and GLP-1 pathways

Its essential to maintain regular contact with a healthcare professional while using GLP-1 medication

Because abdominal fat is often linked to insulin resistance and appetite control, semaglutide can help reduce waistline size in a way that feels more sustainable

The human taste is, after the visual and olfactory sensations, the first potential gateway for controlling qualitative and quantitative features of food intake [3, 4]

While research has shown that semaglutide helps to improve hemoglobin A1c levels (a marker for blood sugar control) and stabilize weight in people with type 2 diabetes, the drug has also been associated with certain gastrointestinal side effects